Home »
“These are extraordinary times,” began Hugh Auchincloss, MD, as he opened up the recent NIH-AACR Cancer, Autoimmunity, and Immunology...
The advent of immunotherapy has led to durable responses for an increasing number of patients, including many who initially...
Immunotherapeutic advances have dramatically changed the treatment landscape for a host of different cancer types. Notably, immune checkpoint inhibitors...
Lung cancer – one of the most commonly diagnosed cancers in the United States – is an area of...
Pediatric cancer, while rare, is a devastating diagnosis that is estimated to affect over 11,000 children in the United...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved wrapped...
The injustices come in many ways. A transgender woman is admitted to the hospital for cancer treatment. Her physicians...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
Immunotherapy is a form of cancer treatment that helps a patient’s own immune system recognize and attack cancer cells....
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....